Date | Time | Place | Session / Title | Role |
April 26 | 1:20 PM - 1:50 PM | Interview Lounge, Level 2 | Left Main Disease: PCI vs. CABG | Moderator |
April 26 | 2:00 PM - 3:00 PM | Room 105, Level 1 | ACC-i2 @ TCTAP 2017 | Chair |
April 26 | 3:04 PM - 3:12 PM | Presentation Theater, Level 1 | Left Main and Bifurcation PCI: Prospects and Challenges Future Perspective on LM Revascularization: From Evidence to Real Practice |
Lecturer |
April 26 | 4:45 PM - 6:00 PM | Coronary Theater, Level 1 | Live Case Session III | Moderator |
April 27 | 9:30 AM - 9:40 AM | Valve Theater, Level 1 | Live Case & Lecture Session III Bioprosthetic Valve Thrombosis(TAVR & SAVR) |
Lecturer |
April 27 | 10:14 AM - 10:18 AM | Presentation Theater, Level 1 | Spotlights of New Clinical Trials & 2017 New Data from AMC Discussion: Asan-MV Registry: Confusing MI Definition in Studies Comparing PCI and CABG |
Discussant |
April 27 | 11:06 AM - 12:18 PM | Presentation Theater, Level 1 | Spotlights of New Clinical Trials & 2017 New Data from AMC | Moderator |
April 27 | 11:14 AM - 11:18 AM | Presentation Theater, Level 1 | Spotlights of New Clinical Trials & 2017 New Data from AMC Discussion: [TCTAP A-004] Early Clinical Outcomes Following "Off-" Versus "On-label" Indications of Bioresorbable Vascular Scaffolds for the Treatment of 1505 Patients with Coronary Artery Disease: Results from the Prospective ¡°Registro Absorb Italiano¡± (RAI Regi |
Discussant |
April 27 | 3:15 PM - 3:25 PM | Coronary Theater, Level 1 | Live Case & Lecture Session VII LAA Occlusion for Stroke Prevention: What Is the Ideal? |
Lecturer |